Search Results - "Hoes, Joske"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands by Schurink‐van ’t Klooster, Tessa M., Siebers, Albert G., Hoes, Joske, Kemenade, Folkert J., Berkhof, Johannes, Bogaards, Johannes A., Melker, Hester E.

    Published in Cancer medicine (Malden, MA) (01-05-2023)
    “…Background The first HPV‐vaccine eligible cohorts in the Netherlands will enter the cervical screening program in 2023. However, a substantial number of young…”
    Get full text
    Journal Article
  2. 2

    Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands by Hoes, Joske, Boef, Anna G C, Knol, Mirjam J, de Melker, Hester E, Mollema, Liesbeth, van der Klis, Fiona R M, Rots, Nynke Y, van Baarle, Debbie

    Published in Frontiers in public health (27-07-2018)
    “…We investigated whether low socioeconomic status (SES), which is associated with reduced health and life expectancy, might play a role in increased risk for…”
    Get full text
    Journal Article
  3. 3

    High vaccine effectiveness persists for ten years after HPV16/18 vaccination among young Dutch women by Hoes, Joske, King, Audrey J., Berkhof, Johannes, de Melker, Hester E.

    Published in Vaccine (09-01-2023)
    “…The current study describes the long-term effectiveness of three-dose HPV16/18 vaccination among Dutch women who were eligible for vaccination during a…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Approaches to Estimating Clearance Rates for Human Papillomavirus Groupings: A Systematic Review and Real Data Examples by Wijstma, Eline S., Jongen, Vita W., Alberts, Catharina J., de Melker, Hester E., Hoes, Joske, Schim van der Loeff, Maarten F.

    Published in Epidemiology (Cambridge, Mass.) (01-01-2023)
    “…Approaches to estimating clearance rates, an important metric of human papillomavirus (HPV) clearance, for HPV groupings differ between studies. We aimed to…”
    Get full text
    Journal Article
  7. 7

    Changes in HPV Seroprevalence from an Unvaccinated toward a Girls-Only Vaccinated Population in the Netherlands by Pasmans, Hella, Hoes, Joske, Tymchenko, Liza, de Melker, Hester E, van der Klis, Fiona R M

    “…In the Netherlands, bivalent human papillomavirus (HPV) vaccination was included in the National Immunization Program for 12-year-old girls in 2010…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Vaccine effectiveness following routine immunization with bivalent HPV vaccine: Protection against incident genital HPV infections from a reduced-dosing schedule by Hoes, Joske, King, Audrey J, Schurink-van 't Klooster, Tessa M, Berkhof, Prof Johannes, Bogaards, Johannes A, de Melker, Hester E

    Published in The Journal of infectious diseases (08-05-2021)
    “…In the Netherlands, the bivalent HPV vaccine (2vHPV) has been offered to preadolescent girls via the National Immunization Program (NIP) in a two-dose (2D)…”
    Get full text
    Journal Article